The Food and Drug Administration has dropped its final guidance document for sponsors and investigators wishing to implement decentralized clinical trials, which can be run remotely to make participation more convenient.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?